Fulminant pneumonitis developed during the middle-dose corticosteroid therapy in systemic lupus erythematosus.
D000328:Adult; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D011014:Pneumonia / Q000209:etiology*; D011239:Prednisolone / Q000008:administration & dosage* / Q000627:therapeutic use
D011239:Prednisolone